1-10 of 10
horner syndrome
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of GSK525762, a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of Phase I/II Open Label Single Agent Study in Patients with Acute Myeloid Leukemia (AML)

Mark Dawson, MD PhD, Eytan M. Stein, MD, Brian J.P Huntly, Anastasios Karadimitris, PhD, Manali Kamdar, Carlos Fernandez de Larrea, Michael J. Dickinson, Paul Sung-Hao Yeh, MBBS, FRCPA, FRACP, Naval Daver, MD, Aristeidis Chaidos, MD PhD, Martin S. Tallman, MD, Raquel Jiménez, MD, Thierry Horner, PhD, January Baron, MS, John Brennan, Geraldine Ferron-Brady, Yuehui Wu, PhD, Natalie Karpinich, Brandon Kremer, Arindam Dhar, MBBS,MDPhD, Gautam Borthakur, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1377.
https://doi.org/10.1182/blood.V130.Suppl_1.1377.1377
Published: 2017
Journal Articles

A Phase I/II Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Subjects with Relapsed, Refractory Hematologic Malignancies

Gautam Borthakur, MD, Mark A Dawson, MD PhD, Eytan M. Stein, MD, Anastasios Karadimitris, Brian J.P Huntly, MD PhD, Michael J. Dickinson, MBBS, FRACP, FRCPA, Aristeidis Chaidos, Thierry Horner, PhD, John Brennan, January Baron, Brandon E. Kremer, MD PhD, Arindam Dhar, MBBS, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5223.
https://doi.org/10.1182/blood.V128.22.5223.5223
Published: 2016
Journal Articles

A Phase I Study of GSK2816126, an Enhancer of Zeste Homolog 2(EZH2) Inhibitor, in Patients (pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Other Non-Hodgkin Lymphomas (NHL), Transformed Follicular Lymphoma (tFL), Solid Tumors and Multiple Myeloma (MM)

Timothy A. Yap, MD PhD, Jane N. Winter, MD, John P. Leonard, MD, Vincent Ribrag, MD, Anastasia Constantinidou, MD, Lisa Giulino-Roth, MD, Jean-Marie Michot, MD, Tariq A Khan, MD, Thierry Horner, PhD, Jennifer Carver, Teodora Pene Dumetrescu, PhD, Zangdong He, PhD, Michael T. McCabe, PhD, Caretha L. Creasy, PhD, Arindam Dhar, MBBS, MD PhD, Christopher Carpenter, MD PhD, Peter M Johnson, MA, MD
Journal: Blood
Blood (2016) 128 (22): 4203.
https://doi.org/10.1182/blood.V128.22.4203.4203
Published: 2016
Journal Articles

Tositumomab and I 131 Tositumomab Achieves Complete Remissions Lasting > 10 Years In Patients with Chemotherapy-Refractory Low-Grade and Transformed B-Cell Lymphomas

Mark S. Kaminski, MD, Andrew D. Zelenetz, MD, Oliver W. Press, MD, PhD, Mansoor N. Saleh, MD, John P. Leonard, MD, Louis Fehrenbacher, MD, T. Andrew Lister, MD, Thierry J. Horner, PhD, Vanessa C. Williams, MS, Thomas S. Lin, MD, PhD, Christina Vleisides, DC, Susan J. Knox, MD, PhD, Richard L. Wahl, MD, Julie M. Vose
Journal: Blood
Blood (2010) 116 (21): 3960.
https://doi.org/10.1182/blood.V116.21.3960.3960
Published: 2010
Journal Articles

Comparison of Dosimetry and Gamma Camera Methods for Evaluation of Biodistribution Prior to Administration of the Therapeutic Dose of Tositumomab and Iodine I 131 Tositumomab (Bexxar Therapeutic Regimen)

Thierry J. Horner, PhD, Jeffry A. Siegel, MS, MS, PhD, Roxanne C. Jewell, PhD, Gary J. Lunger, MSRIS, RT(R)(N)ARRT, Nancy L. Young, BS, NMT, Brian R. Wynne, MD, Vanessa C. Williams, MS, Thomas S. Lin, MD, PhD, Mark S. Kaminski, MD, Richard L. Wahl, MD, Christina Vleisides, DC
Journal: Blood
Blood (2010) 116 (21): 4916.
https://doi.org/10.1182/blood.V116.21.4916.4916
Published: 2010
Journal Articles

REFRACTORY Blastic Extramedullary Plasmacytoma

Sebastian Trainor, MB, BCh, BAO, D. S O'Briain, MB, BCh, BAO, MRCPath, Charles Gillham, MRCP, FRCR, Deirdre O'Mahony, MB, BCh, BAO, MRCP(UK), MSc
Journal: Blood
Blood (2010) 116 (21): 5102.
https://doi.org/10.1182/blood.V116.21.5102.5102
Published: 2010
Journal Articles

Tositumomab and Iodine I-131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma: Median 10 Year Follow-up Results.

Mark S. Kaminski, MD, Melissa Tuck, MS, Judith Estes, BSN, MSN, Arne Kolstad, MD, PhD, Charles Warren Ross, MD, Denise Regan, BS, Thierry Horner, PhD, Vanessa C. Williams, MS, Tina Vleisides, DC, Richard L. Wahl, MD
Journal: Blood
Blood (2009) 114 (22): 3759.
https://doi.org/10.1182/blood.V114.22.3759.3759
Published: 2009
Journal Articles

Tositumomab and Iodine I-131 Tositumomab (Bexxar® therapeutic regimen) for Non-Hodgkin's Lymphoma Patients Who Progressed After Treatment with Rituximab: Long Term Follow-up of a Multi-Center Phase II Study.

Sandra J Horning, MD, Anas Younes, MD, Donald Podoloff, MD, Thierry J Horner, PhD, Vanessa C Williams, MS, Christina Vleisides, Michael Goris, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2732.
https://doi.org/10.1182/blood.V114.22.2732.2732
Published: 2009
Journal Articles

A Case Report of Aggressive Adult Neuroblastoma Mimicking Acute Leukemia with Fulminant Course and Fatal Outcome

Irina Panovska, MD, Martin Ivanovski, Sanja Trajkova, Aleksandra Pivkova, Sonja Genadieva-Stavric, Liljana Hadzi-Pecova, Arif Latifi, Dejan Trajkov, Mirko Spiroski, Lidija Cevreska
Journal: Blood
Blood (2008) 112 (11): 4893.
https://doi.org/10.1182/blood.V112.11.4893.4893
Published: 2008
Journal Articles

Carotid and Vertebral Artery Dissection Syndromes.

Beatriz Grand, MD, Jorge Solimano, MD, Adriana Ventura, Ernesto Quiroga Micheo, MD, Dardo Riveros, MD
Journal: Blood
Blood (2005) 106 (11): 4145.
https://doi.org/10.1182/blood.V106.11.4145.4145
Published: 2005